VERU INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages Veru Inc. (VERU) ...
Hagens Berman urges Veru Inc. (NASDAQ: VERU) investors with significant losses to submit your losses now.
SAN FRANCISCO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Veru Inc. (NASDAQ: VERU) investors with significant losses to submit your losses now.
Class Period: May 11, 2022 – Nov. 9, 2022
Lead Plaintiff Deadline: Feb. 6, 2023
Visit: www.hbsslaw.com/investor-fraud/VERU
Contact An Attorney Now: VERU@hbsslaw.com
844-916-0895
Veru Inc. (NASDAQ: VERU) Securities Fraud Class Action:
The complaint alleges that throughout the Class Period, Defendants misrepresented and concealed material adverse facts about the data from the Phase 3 trial and the Company’s interactions with the FDA concerning sabizabulin (VERU-111), its orally administered COVID 19 drug intended to treat hospitalized patients at high risk for acute respiratory distress syndrome.
